𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Improvement of Neuromuscular Transmission by 3,4-Diaminopyridine in the Lambert-Eaton Myasthenic Syndrome and in Myasthenia Gravis

✍ Scribed by I. ROSÉN; H. LUNDH; O. NILSSON

Book ID
119860711
Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
130 KB
Volume
505
Category
Article
ISSN
0890-6564

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Improvement in Neuromuscular transmissio
Improvement in Neuromuscular transmission in Myasthenia Gravis by 3,4-Diaminopyridine
✍ H. Lundh; O. Nilsson; I. Rosén 📂 Article 📅 1985 🏛 Springer-Verlag 🌐 English ⚖ 361 KB

3,4-Diaminopyridine ( 3,4-DAP), a potent potentiator of action potential evoked release of acetylcholine from presynaptic terminals in the neuromuscular junction was given i v and p o to two patients with myasthenia gravis. Effects were monitored electrophysiologically by repetitive nerve stimulatio

Single-fiber electromyography improvemen
Single-fiber electromyography improvement with 3,4-diaminopyridine in Lambert–Eaton myasthenic syndrome
✍ Dae S. Kim; Gwendolyn C. Claussen; Shin J. Oh 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 2 views

The high incidence of elevated immunoglobulin (Ig)G anti-GQ1b antibody in sera from patients with acute phase Miller-Fisher syndrome (MFS) was first reported by Chiba et al. 1 and later confirmed by two other groups. 3,4 Chiba et al. 2 pointed out that anti-GQ1b IgG antibody is associated specifical